L
László Wagner
Researcher at Semmelweis University
Publications - 61
Citations - 975
László Wagner is an academic researcher from Semmelweis University. The author has contributed to research in topics: Diabetes mellitus & Transplantation. The author has an hindex of 17, co-authored 57 publications receiving 854 citations. Previous affiliations of László Wagner include University of Florida & University of Pécs.
Papers
More filters
Journal ArticleDOI
Prevention and treatment of diabetic nephropathy
István Wittmann,Gergő A. Molnár,Péter Degrell,Zoltán Wagner,Mónika Tamaskó,Boglárka Laczy,Pál Brasnyó,László Wagner,Judit Nagy +8 more
TL;DR: Improvement of carbohydrate metabolism with a consequential decrease in the formation of AGE is an important contributor to the prevention and treatment of diabetic nephropathy and atherosclerosis.
Journal ArticleDOI
Serum Carboxymethyllysine Predicts Mortality in Hemodialysis Patients
Zoltán Wagner,Márta Molnár,Gergő A. Molnár,Mónika Tamaskó,Boglárka Laczy,László Wagner,Botond Csiky,August Heidland,Judit Nagy,István Wittmann +9 more
TL;DR: The AGE CML may contribute to increased mortality in patients with uremia, and the following parameters proved to be independent risk factors of all-cause mortality.
Journal ArticleDOI
Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase
TL;DR: Elevated NO production in WF rats was associated with protection from the progression of CRD after renal mass reduction, and might be attributable to greater total and renal NO-generating capacity and increased nephron number, compared with SD rats.
Journal ArticleDOI
Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
TL;DR: There is no diurnal blood pressure variation in most of the hypertensive IgA nephropathy patients and ACEI and CCB treatment have better effect on day-time than night-time hypertension.
Journal ArticleDOI
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Sandor Koszegi,Agnes Molnar,Agnes Molnar,Lilla Lenart,Judit Hodrea,Dora Balogh,Dora Balogh,Tamas Lakat,Edgar Szkibinszkij,Edgar Szkibinszkij,Adam Hosszu,Adam Hosszu,Nadja Sparding,Federica Genovese,László Wagner,Ádám Vannay,Attila J. Szabo,Attila J. Szabo,Andrea Fekete,Andrea Fekete +19 more
TL;DR: RAASi is found to ameliorate diabetes‐induced renal interstitial fibrosis and decrease profibrotic growth factor production, suggesting a novel therapeutic indication and potential of RAASi in the treatment of renal fibrosis.